Bionano Genomics, Inc. (BNGO) vs GlucoTrack, Inc. (GCTK)

Bionano Genomics, Inc. and GlucoTrack, Inc. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. is the larger, with a market value of $19.9M against $1.9M — 10.8× the size. Bionano Genomics, Inc. grew revenue faster over the last twelve months: 10.0% against −60.6%. GlucoTrack, Inc. has the higher net margin (0.00% vs −106.6%) and the higher return on invested capital (0.00% vs −81.7%). Across the 17 metrics below, Bionano Genomics, Inc. leads on 9 and GlucoTrack, Inc. on 8.

Valuation

Metric BNGO GCTK Medical Instruments & Supplies median
P/E n/m n/m 34.17
P/S 0.64 2.92 2.83
P/B 0.61 n/m 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 0.49 6.85 3.06
Earnings yield (180.84%) (7,562.14%) (1.84%)
Free cash flow yield (106.75%) (2,683.44%) 0.17%

Profitability

Metric BNGO GCTK Medical Instruments & Supplies median
Gross margin 47.51% 0.00% 54.62%
Operating margin (106.67%) 0.00% 1.64%
Net margin (106.58%) 0.00% 0.00%
Free cash flow margin (67.87%) 0.00% 1.61%
Return on equity (83.56%) (620.63%) 0.00%
Return on assets (52.04%) (272.48%) 0.00%
Return on invested capital (81.68%) 0.00% 0.00%

Growth

Metric BNGO GCTK Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% (60.61%) 9.20%
EPS growth (last fiscal year) 94.50% 99.24% —
Revenue growth, 5-year CAGR 27.37% 28.31% 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNGO GCTK Medical Instruments & Supplies median
Debt to equity 0.11 (1.11) 0.08
Current ratio 2.48 0.46 2.49
Net debt to EBITDA 1.06 0.25 0.83

Dividend

Metric BNGO GCTK Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric BNGO GCTK Medical Instruments & Supplies median
Market cap 19.90m 1.85m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack